Published in Calif Med on August 01, 1969
Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis. J Exp Med (1961) 10.94
Role of chemotaxis in inflammation. Physiol Rev (1954) 8.58
THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITRO. J Exp Med (1965) 8.31
Further studies on the chemotactic factor of complement and its formation in vivo. Immunology (1966) 7.59
Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum. J Exp Med (1969) 7.43
BOUND COMPLEMENT AND IMMUNOLOGIC INJURY OF BLOOD VESSELS. J Exp Med (1965) 7.16
Properties of guinea pig 7S antibodies. III. Identification of antibodies involved in complement fixation and hemolysis. J Exp Med (1963) 6.63
A comparative histologic and immunologic study in rabbits of induced hypersensitivity of the serum sickness type. J Exp Med (1953) 6.10
A ROLE OF POLYMORPHONUCLEAR LEUKOCYTES AND COMPLEMENT IN NEPHROTOXIC NEPHRITIS. J Exp Med (1965) 5.86
Similarities in the mechanisms determining the Arthus and Shwartzman phenomena. J Exp Med (1951) 5.81
Gamma globulin complexes in rheumatoid arthritis and certain other conditions. J Clin Invest (1961) 5.62
The role of polymorphonuclear leukocytes in the initiation and cessation of the Arthus vasculitis. J Exp Med (1959) 5.60
A plasmin-split fragment of C'3 as a new chemotactic factor. J Exp Med (1967) 4.94
Immunohistochemical study of lesions in rheumatic fever, systemic lupus ervthematosus, and rheumatoid arthritis. Lab Invest (1957) 4.57
A neutrophil chemotactic factor from human C'5. J Immunol (1969) 4.46
The release of histamine and 5-hydroxytryptamine (serotonin) from platelets by antigen-antibody reactions (in vitro). J Physiol (1955) 4.40
The localization of circulating immune complexes in experimental serum sickness. The role of vasoactive amines and hydrodynamic forces. J Exp Med (1968) 4.29
POSSIBLE ROLE OF LEUCOCYTE GRANULES IN THE SHWARTZMAN AND ARTHUS REACTIONS. Proc Soc Exp Biol Med (1964) 4.02
Analytical pathology. III. New observations on the pathogenesis of glomerulonephritis, lipid nephrosis, periarteritis nodosa, and secondary amyloidosis in man. Am J Pathol (1956) 4.01
The cutaneous reaction to soluble antigen-antibody complexes; a comparison with the Arthus phenomenon. J Exp Med (1958) 3.92
STUDIES ON THE LOCALIZATION OF CIRCULATING ANTIGEN-ANTIBODY COMPLEXES AND OTHER MACROMOLECULES IN VESSELS. I. STRUCTURAL STUDIES. J Exp Med (1963) 3.83
Periarteritis nodosa; a critical review. Am J Clin Pathol (1952) 3.70
An electron microscope study of the glomerulus in nephrosis, glomerulonephritis, and lupus erythematosus. J Exp Med (1957) 3.65
Polymorphonuclear leukocytes in immunologic reactions. The destruction of vascular basement membrane in vivo and in vitro. J Exp Med (1966) 3.57
Studies on the biological properties of antigen-antibody complexes. I. Anaphylatic shock induced by soluble antigen-antibody complexes in unsensitized normal guinea pigs. Bull Johns Hopkins Hosp (1957) 3.33
Mediators of inflammation in leukocyte lysosomes. IX. Elastinolytic activity in granules of human polymorphonuclear leukocytes. J Exp Med (1968) 3.12
PATHOGENIC FACTORS IN VASULAR LESIONS OF EXPERIMENTAL SERUM SICKNESS. J Exp Med (1965) 3.03
The mechanism of Arthus reactions. II. The role of polymorphonuclear leucocytes and platelets in reversed passive reactions in the guinea-pig. Br J Exp Pathol (1955) 2.97
The mechanism of Arthus reactions. I. The role of polymorphonuclear leucocytes and other factors in reversed passive Arthus reactions in rabbits. Br J Exp Pathol (1955) 2.83
SUBSTANCES PROMOTING LEUKOCYTE EMIGRATION. Ann N Y Acad Sci (1964) 2.62
The pathologic effects of intravenously administered soluble antigen-antibody complexes. I. Passive serum sickness in mice. J Exp Med (1960) 2.36
Vascular injury and lysis of basement membrane in vitro by neutral protease of human leukocytes. Science (1968) 2.30
Mediators of inflammation in leukocyte lysosomes. II. Mechanism of action of lysosomal cationic protein upon vascular permeability in the rat. J Exp Med (1965) 2.13
A PERMEABILITY FACTOR RELEASED FROM LEUKOCYTES AFTER PHAGOCYTOSIS OF IMMUNE COMPLEXES AND ITS POSSIBLE ROLE IN THE ARTHUS REACTION. Life Sci (1964) 2.12
PROPERTIES OF VARIOUS ANTI-GAMMA-GLOBULIN FACTORS IN HUMAN SERA. J Exp Med (1965) 2.01
Isolation and characterization of permeability factors from rabbit neutrophils. J Exp Med (1968) 2.00
The release of histamine from rabbit platelets by means of antigen-antibody precipitates. I. The participation of the immune complex in histamine release. J Immunol (1961) 1.98
STUDIES ON THE LOCALIZATION OF CIRCULATING ANTIGEN-ANTIBODY COMPLEXES AND OTHER MACROMOLECULES IN VESSELS. II. PATHOGENETIC AND PHARMACODYNAMIC STUDIES. J Exp Med (1963) 1.92
The purification and properties of a proteolytic enzyme, rabbit cathepsin E, and further studies on rabbit cathepsin D. Biochem J (1962) 1.91
Biological activity of soluble antigen-antibody complexes. I. Skin reactive properties. Proc Soc Exp Biol Med (1958) 1.88
Studies of aggregated gamma-globulin. II. Effect in vivo. J Immunol (1960) 1.85
Stimulating action of soluble antigen-antibody complexes on normal guinea-pig smooth muscle. Science (1958) 1.69
RHEUMATOID FACTOR PROPERTIES OF HYPERIMMUNE RABBIT SERA. J Exp Med (1963) 1.46
Delayed leucocytic emigration after intra-dermal injections and thermal injury. J Pathol Bacteriol (1961) 1.40
Characterization of the antibody response. J Cell Physiol Suppl (1957) 1.32
Diffuse glomerulonephritis induced in rabbits by small intravenous injections of horse serum. AMA Arch Pathol (1951) 1.29
Immunocytochemical observations in periarteritis nodosa. Ann Intern Med (1962) 1.15
Biologic activity of soluble antigen-antibody complexes. IV. The inhibition of the skin reactivity of soluble complexes and the PCA reaction by heterologous complexes. J Immunol (1959) 1.04
Complement fixation in diseased tissues. II. Fixation of guinea pig complement in renal lesions of systemic lupus erythematosus. Am J Pathol (1963) 1.00
LUPUS ERYTHEMATOSUS WITH FATAL HEMORRHAGE INTO THE LIVER AND LESIONS RESEMBLING THOSE OF PERIARTERITIS NODOSA AND MALIGNANT HYPERTENSION. IMMUNOCYTOCHEMICAL OBSERVATIONS. Am J Med (1964) 0.99
A method of trace iodination of proteins for immunologic studies. Int Arch Allergy Appl Immunol (1966) 43.66
Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med (1978) 11.99
Murine models of systemic lupus erythematosus. Adv Immunol (1985) 9.79
Pathogenesis of the glomerulonephritis of NZB/W mice. J Exp Med (1968) 8.91
The Raji cell radioimmune assay for detecting immune complexes in human sera. J Clin Invest (1976) 8.06
Further studies on the chemotactic factor of complement and its formation in vivo. Immunology (1966) 7.59
Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum. J Exp Med (1969) 7.43
Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them. J Immunol (1969) 6.97
The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med (1967) 6.81
Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions. J Immunol (1970) 6.58
Pathogenesis of chronic disease associated with persistent lymphocytic choriomeningitis viral infection. I. Relationship of antibody production to disease in neonatally infected mice. J Exp Med (1969) 6.03
The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement. J Exp Med (1968) 5.78
Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor. J Exp Med (1972) 5.38
Immune complex disease in experimental animals and man. Adv Immunol (1973) 5.30
Autologous immune complex nephritis induced with renal tubular antigen. I. Identification and isolation of the pathogenetic antigen. J Exp Med (1968) 4.79
Etiopathogenesis of murine SLE. Immunol Rev (1981) 4.39
The localization of circulating immune complexes in experimental serum sickness. The role of vasoactive amines and hydrodynamic forces. J Exp Med (1968) 4.29
Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05
Lymphocytic choriomeningitis: production of antibody by "tolerant" infected mice. Science (1967) 4.01
Autologous immune-complex pathogenesis of experimental allergic glomerulonephritis. Science (1967) 3.96
Experimental glomerulonephritis: immunological events and pathogenetic mechanisms. Adv Immunol (1967) 3.83
Immunologic tissue injury mediated by neutrophilic leukocytes. Adv Immunol (1968) 3.82
Studies on circulating immune complexes. 3. Factors governing the ability of circulating complexes to localize in blood vessels. J Exp Med (1968) 3.80
Increased spontaneous polyclonal activation of B lymphocytes in mice with spontaneous autoimmune disease. J Immunol (1978) 3.78
Serum transfer of collagen-induced arthritis in mice. J Exp Med (1983) 3.74
The pathogenesis of glomerulonephritis. Am J Med (1968) 3.61
Presence of anti-Sm reactivity in autoimmune mouse strains. J Exp Med (1978) 3.58
Polymorphonuclear leukocytes in immunologic reactions. The destruction of vascular basement membrane in vivo and in vitro. J Exp Med (1966) 3.57
Endogenous oncornaviral gene expression in adult and fetal mice: quantitative, histologic, and physiologic studies of the major viral glycorprotein, gp70. J Exp Med (1976) 3.51
Autologous immune complex nephritis induced with renal tubular antigen. II. The pathogenetic mechanism. J Exp Med (1968) 3.40
The effect of passively administered antibody on antibody synthesis. J Exp Med (1967) 3.31
Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2. J Exp Med (1981) 3.27
Activation of Hageman factor in solid and fluid phases. A critical role of kallikrein. J Exp Med (1973) 3.15
Anti-glomerular basement membrane antibody-induced glomerulonephritis. Kidney Int (1973) 3.09
The biology and detection of immune complexes. Adv Immunol (1979) 3.05
Acute immune complex disease in rabbits. The role of complement and of a leukocyte-dependent release of vasoactive amines from platelets. J Exp Med (1971) 2.92
IgM rheumatoid factors in mice injected with bacterial lipopolysaccharides. J Immunol (1979) 2.86
Association of circulating retroviral gp70-anti-gp70 immune complexes with murine systemic lupus erythematosus. J Exp Med (1979) 2.86
A spontaneous rheumatoid arthritis-like disease in MRL/l mice. J Exp Med (1982) 2.76
The potential pathogenic role of complement in dengue hemorrhagic shock syndrome. N Engl J Med (1973) 2.64
Mechanism and modification of rejection of heterografts between divergent species. Transplant Proc (1970) 2.63
Distribution of lymphocytes identified by surface markers in murine strains with systemic lupus erythematosus-like syndromes. J Exp Med (1979) 2.55
The antibody response of mice to murine leukemia virus in spontaneous infection: absence of classical immunologic tolerance (AKR mice-complement-fixing antibodies-lymphocytic choriomeningitis virus-immunofluorescence-glomerular deposits of antigen-antibody complexes). Proc Natl Acad Sci U S A (1972) 2.54
Binding of soluble immune complexes to human lymphoblastoid cells. II. Use of Raji cells to detect circulating immune complexes in animal and human sera. J Exp Med (1974) 2.51
Transfer of ovine experimental allergic glomerulonephritis (EAG) with serum. J Exp Med (1966) 2.42
Purified cytochrome b from human granulocyte plasma membrane is comprised of two polypeptides with relative molecular weights of 91,000 and 22,000. J Clin Invest (1987) 2.40
Histocompatibility-linked genetic control of disease susceptibility. Murine lymphocytic choriomeningitis virus infection. J Exp Med (1973) 2.39
Humoral antibodies and coagulation mechanisms in the accelerated or hyperacute rejection of renal homografts in sensitized canine recipients. Surgery (1970) 2.38
The oncornavirus glycoprotein gp69/71: a constituent of the surface of normal and malignant thymocytes. J Exp Med (1975) 2.37
Pathogenesis of the adult respiratory distress syndrome. Evidence of oxidant activity in bronchoalveolar lavage fluid. J Clin Invest (1983) 2.37
Clotting changes, including disseminated intravascular coagulation, during rapid renal-homograft rejection. N Engl J Med (1970) 2.33
Immunological induction of increased vascular permeability. II. Two mechanisms of histamine release from rabbit platelets involving complement. J Exp Med (1969) 2.30
Glomerular basement membrane damage in immunological glomerulonephritis. Immunology (1968) 2.29
Characterization and isolation of specific renal tubular epithelial antigens. J Immunol (1967) 2.25
Binding of soluble immune complexes to human lymphoblastoid cells. I. Characterization of receptors for IgG Fc and complement and description of the binding mechanism. J Exp Med (1974) 2.22
The effect of induced chronic viral infections on the immunologic diseases of New Zealand mice. J Exp Med (1970) 2.16
Identification of a B cell differentiation factor(s) spontaneously produced by proliferating T cells in murine lupus strains of the lpr/lpr genotype. J Exp Med (1983) 2.15
Immunopathogenicity and oncogenicity of murine leukemia viruses. I. Induction of immunologic disease and lymphoma in (BALB-c times NZB)F1 mice by Scripps leukemia virus. J Exp Med (1974) 2.12
Immunohistochemical study of allergic encephalomyelitis. Am J Pathol (1968) 2.10
Oxidant injury of cells. DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide. J Clin Invest (1986) 2.08
Pathogenesis of the slow disease of the central nervous system associated with WM 1504 E virus. I. Relationship of strain susceptibility and replication to disease. Am J Pathol (1977) 2.08
Influence of thymic genotype on the systemic lupus erythematosus-like disease and T cell proliferation of MRL/Mp-lpr/lpr mice. J Exp Med (1981) 2.07
Diagnosis of immunopathologic renal disease. Kidney Int (1974) 2.07
Splenic immunoglobulin-secreting cells and their regulation in autoimmune mice. J Exp Med (1980) 2.07
Induction of murine autoimmune disease by chronic polyclonal B cell activation. J Exp Med (1983) 2.06
Mechanisms of oxidant-mediated cell injury. The glycolytic and mitochondrial pathways of ADP phosphorylation are major intracellular targets inactivated by hydrogen peroxide. J Biol Chem (1988) 2.03
Circulating immune complexes in infective endocarditis. N Engl J Med (1976) 2.02
Radioiodination of proteins by the use of the chloramine-T method. Methods Enzymol (1980) 2.01
Tissue injury in lymphocytic choriomeningitis viral infection: virus-induced immunologically specific release of a cytotoxic factor from immune lymphoid cells. Virology (1970) 2.00
Isolation and characterization of permeability factors from rabbit neutrophils. J Exp Med (1968) 2.00
Immune response to a hapten coupled to a nonimmunogenic carrier. Influence of lipopolysaccharide. J Exp Med (1972) 1.95
Antigen quantitation in experimental immune complex glomerulonephritis. I. Acute serum sickness. J Immunol (1970) 1.93
Receptor for soluble C3 and C3b on human lymphoblastoid (RAJI) cells. Properties and biologocal significance. J Exp Med (1974) 1.91
Mediation systems in bacterial lipopolysaccharide-induced hypotension and disseminated intravascular coagulation. I. The role of complement. J Exp Med (1975) 1.91
Experimental allergic glomerulonephritis induced in the rabbit with heterologous renal antigens. J Exp Med (1967) 1.90
The nature of immune complexes in human cancer sera. J Immunol (1977) 1.88
Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase. Proc Natl Acad Sci U S A (1986) 1.87
Comparison of the immune responsiveness of NZB and NZB X NZW F1 hybrid mice with that of other strains of mice. J Exp Med (1969) 1.87
Mediators of the arthus and related reactions. Prog Allergy (1967) 1.85
Farnesol modification of Kirsten-ras exon 4B protein is essential for transformation. Proc Natl Acad Sci U S A (1990) 1.84
Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia. J Clin Invest (1983) 1.83
Analysis of vascular lesions in murine SLE. I. Association with serologic abnormalities. J Immunol (1983) 1.81
Detection of tissue kallikrein in the bronchoalveolar lavage fluid of asthmatic subjects. J Clin Invest (1987) 1.80
B cell dependence on and response to accessory signals in murine lupus strains. J Exp Med (1983) 1.79
Experimental allergic glomerulonephritis induced in the rabbit with homologous renal antigens. J Exp Med (1967) 1.76
The antibody responses of rabbits and rats to hemocyanin. J Immunol (1966) 1.75
Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins). J Exp Med (1974) 1.74
Quantitation of acute and chronic serum sickness in the rabbit. J Exp Med (1971) 1.74
Characterization of human anti-glomerular basement membrane antibodies eluted from glomerulonephritic kidneys. J Clin Invest (1970) 1.70
Immune complex disease in chronic viral infections. J Exp Med (1971) 1.69
The induction of acute glomerulonephritis in rabbits with soluble antigens isolated from normal homologous and autologous urine. J Immunol (1968) 1.68
Studies on the pathogenesis of the adult respiratory distress syndrome. J Clin Invest (1982) 1.68
Detection of circulating immune complexes in patients with glomerulonephritis. Kidney Int (1977) 1.66
The first component of the kinin-forming system in human and rabbit plasma. Its relationship to clotting factor XII (Hageman Factor). J Exp Med (1971) 1.65
Karyotypic, virologic, and immunologic analyses of two continuous lymphocyte lines established from New Zealand black mice: possible relationship of chromosomal mosaicism to autoimmunity. Proc Natl Acad Sci U S A (1972) 1.65
Plasma prekallikrein: isolation, characterization, and mechanism of activation. J Exp Med (1972) 1.62
Transfer of human systemic lupus erythematosus in severe combined immunodeficient (SCID) mice. J Exp Med (1990) 1.61
Genesis of antinuclear antibody in NZB-W mice: role of genetic factors and of viral infections. Clin Exp Immunol (1970) 1.59
Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor. Proc Natl Acad Sci U S A (1976) 1.59